Her suggestions for holding on to lean mass on GLP-1 drugs are protein, resistance training and tracking body composition, not just watching the scale.
Recap by typeshit. Video by @mj.gandon on TikTok.
8:58
Constable, who bills herself as a peptide expert, lists side effects she links to the unapproved triple agonist. Her claims, not trial data, so weigh them accordingly.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
A $90 Brooklyn vial held a filler used in lip balm plus 13 bacteria colonies, University of Iowa testers said. Two online orders shipped with no consultation.
A systematic review cited by Dr. Axe found human safety data on BPC-157 comes from just 30 people, a thin base for a widely used peptide.
A post on the trial pitting Lilly's tirzepatide against dulaglutide for cardiovascular outcomes in people with type 2 diabetes.
Medscape walks through the basics of orforglipron, Lilly's oral GLP-1 sold as Foundayo, as the pill moves toward approval in Europe.
Loading…